Decorative image


Read about why there is no screening programme for hairy cell leukaemia.

What screening is

Screening means testing people for early stages of an illness before they have any symptoms. For screening to be useful the tests:

  • must be reliable at picking up the illness
  • must be simple and quick
  • overall must do more good than harm to people taking part

No screening available

There is no national screening programme for hairy cell leukaemia because:

  • this condition is rare, so many people would have unnecessary tests
  • the benefits don't outweigh the costs

With rare diseases it is more cost effective to screen people who are thought to be at higher risk. But first we need to be sure who is at higher risk.

Talk to your GP if you are worried about your risk of developing cancer.

Last reviewed: 
31 Mar 2015
  • Hairy cell leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    T Robak  and others on behalf of the ESMO Guidelines Committee
    Annals of Oncology, 2015. Volume 26, Supplement 5

  • Current therapeutic options in hairy cell leukemia
    E Mikler and others
    Journal of Community and Support Oncology, 2014. Volume 12, Issue 3

Information and help

Dangoor sponsorship

About Cancer generously supported by Dangoor Education since 2010.